Dzarieva, F.; Pavlova, S.; Fab, L.; Shamadykova, D.; Revishchin, A.; Alekseeva, A.; Kopylov, A.; Pronin, I.; Pavlova, G.
New Player in the Field of Glioblastoma Therapy: EGFRvIII-Specific Gol1 Aptamer Shows a Great Therapeutic Potential. Pharmaceutics 2026, 18, 299.
https://doi.org/10.3390/pharmaceutics18030299
AMA Style
Dzarieva F, Pavlova S, Fab L, Shamadykova D, Revishchin A, Alekseeva A, Kopylov A, Pronin I, Pavlova G.
New Player in the Field of Glioblastoma Therapy: EGFRvIII-Specific Gol1 Aptamer Shows a Great Therapeutic Potential. Pharmaceutics. 2026; 18(3):299.
https://doi.org/10.3390/pharmaceutics18030299
Chicago/Turabian Style
Dzarieva, Fatima, Svetlana Pavlova, Lika Fab, Dzhirgala Shamadykova, Alexander Revishchin, Anna Alekseeva, Alexey Kopylov, Igor Pronin, and Galina Pavlova.
2026. "New Player in the Field of Glioblastoma Therapy: EGFRvIII-Specific Gol1 Aptamer Shows a Great Therapeutic Potential" Pharmaceutics 18, no. 3: 299.
https://doi.org/10.3390/pharmaceutics18030299
APA Style
Dzarieva, F., Pavlova, S., Fab, L., Shamadykova, D., Revishchin, A., Alekseeva, A., Kopylov, A., Pronin, I., & Pavlova, G.
(2026). New Player in the Field of Glioblastoma Therapy: EGFRvIII-Specific Gol1 Aptamer Shows a Great Therapeutic Potential. Pharmaceutics, 18(3), 299.
https://doi.org/10.3390/pharmaceutics18030299